Lessons from Ebola Outbreak Speed Funding and Compassion May Guide Future Pandemic Preparedness Iran Intensifies Strategic Claims Over Strait of Hormuz with New Military Oversight Map Bitcoin Drops to 13th Largest Global Asset as Capital Rotates Into AI and Precious Metals US Jobless Claims Drop to Lowest Since MidMay Signaling Labor Market Resilience Goldman Sachs Russias Crude Exports Remain Stable Despite Latest US Sanctions Oil Edges Lower 73YearOld With 15 Million 401k May Face 280000 Cumulative RMD Tax Bill BOH Q1 2026 Earnings EPS Misses Estimates as Stock Slips ASBA Q1 2026 Earnings EPS Slightly Beats Estimates Note Price Unchanged Purple Biotech Q1 2025 Earnings DevelopmentStage Focus Drives Investor Sentiment NVMI Q1 2026 Earnings Solid EPS Beat Lifts Shares Amid Steady Demand MGRB Q1 2026 Earnings EPS Beats Estimates Bond Price Edges Higher on Steady Performance ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher Nuveen Dynamic Municipal Opportunities Fund NDMO Creeps Higher Consolidating in a Narrow Range AGCO Corporation AGCO Holds Steady Near Key Support After Minor Decline StoneX Group SNEX Holds Steady Near 112 as Support Levels Are Tested Electronic Arts EA Holds Steady Near Midpoint as Investors Eye Key Levels CryoCell International CCEL Edges Higher Testing Key Resistance After Support Bounce IBM Gains 27 Billion in Market Cap After Trumps 2 Billion Quantum Computing Push GEGGL Q1 2026 Earnings Significant EPS Miss with No Revenue Reported BristolMyers Squibb BMY Declines 218 Support Levels in Focus as Stock Holds Above 55 JAKK Q1 2026 Earnings NarrowerThanExpected Loss Lifts Investor Sentiment DANA Incorporated Q1 2026 Earnings Profit Miss Weighs on Sentiment Despite Share Gain VMD Q1 2026 Earnings EPS Misses Estimates by 34 Amid Uncertain Revenue Outlook AKR Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher Intergroup Corporation INTG Q1 2026 Earnings Positive EPS as Stock Advances Despite Sparse Disclosure ST Q1 2026 Earnings EPS Slightly Beats Consensus Stock Gains Lineage Cell Therapeutics Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Pipeline Investment